EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Performance of DOAC and HAS-BLED scores in predicting major bleeding in Asian patients with non-valvular atrial fibrillation receiving direct oral anticoagulants

Yi-Hsin Chan iD, Yi-Wei Kao iD, Shao-Wei Chen iD, Tze-Fan Chao iD

Europace · 31.10.2025 · 27 (11)

DOI: 10.1093/europace/euaf251 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Europace, online erschienen am 03.10.2025. Verfasst von Yi-Hsin Chan und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Factor Xa Inhibitors, Hemorrhage, Stroke. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The direct oral anticoagulant (DOAC) score was recently developed to predict bleeding risk in patients with atrial fibrillation (AF) receiving oral anticoagulants. However, limited data show inconsistent results comparing its performance to the conventional HAS-BLED score in Asian populations with non-valvular AF receiving DOACs. Methods and results We enrolled 21 142 patients with non-valvular AF receiving DOACs from a multicentre database in Taiwan (June 2012–December 2021). The primary endpoint was major bleeding events. Major bleeding events were defined according to the ISTH criteria. Areas under receiver operating characteristic curves (AUCs) were calculated for each score, with differences assessed using DeLong test. A total of 21 142 AF patients (mean age 75.9 ± 11.0 years; 41% female) treated with DOAC were included in the analysis. Major bleeding events occurred in 681 patients in 1-year follow-up (3.66%/year). There were 82(0.43%/year) intracranial haemorrhage event occurred. Both the DOAC and HAS-BLED scores are associated with a significant risk of major bleeding event, with only modest predictive performance (AUC < 0.7). The DOAC score showed a slightly but statistically significantly higher AUC compared with the HAS-BLED score [AUC: 0.670 (95% CI: 0.650–0.689) vs. 0.642 (0.623–0.663); P < 0.001]. Results from several reclassification analyses favoured the DOAC score. Both the two scores showed a good calibration for the low to intermediate risk categories, while the two bleeding risk scores both overestimate the risk of major bleeding risk for the high risk categories. Subgroup analyses indicated that the superiority of DOAC score over HAS-BLED score is primarily driven by elderly patients (≥75 years) and prediction in risk of gastrointestinal bleeding.

Conclusion

The DOAC score, which employs a more granular scoring system compared to the HAS-BLED score, may enable finer bleeding risk discrimination among Asian patients with non-valvular AF receiving DOAC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationFactor Xa InhibitorsHemorrhageStrokeAgedAged, 80 and overFemaleHumansMaleMiddle AgedAdministration, OralAnticoagulantsPredictive Value of TestsRisk AssessmentRisk FactorsTaiwanEast Asian People

Stichwörter der Autor:innen

Bleeding risk assessmentDOACHAS-BLEDNon-valvular atrial fibrillation

Substanzen

AnticoagulantsFactor Xa Inhibitors

Autor:innen und Institutionen

  • The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
  • College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • School of Traditional Chinese Medicine, College of Medicine, Chang-Gung University, Taoyuan City, Taiwan.
  • Microscopy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
  • Department of Applied Statistics and Information Science, Ming Chuan University, Taoyuan City, Taiwan.
  • Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan.

ORCID-Profile: Yi-Hsin Chan, Yi-Wei Kao, Shao-Wei Chen, Tze-Fan Chao

Förderung

  • Ministry of Science and Technology
  • Chang Gung Memorial Hospital

Zitieren

APA

Chan, Y. H., Kao, Y. W., Chen, S. W., & Chao, T. F. (2025). Performance of DOAC and HAS-BLED scores in predicting major bleeding in Asian patients with non-valvular atrial fibrillation receiving direct oral anticoagulants. Europace, 27(11). https://doi.org/10.1093/europace/euaf251

Vancouver

Chan YH, Kao YW, Chen SW, Chao TF. Performance of DOAC and HAS-BLED scores in predicting major bleeding in Asian patients with non-valvular atrial fibrillation receiving direct oral anticoagulants. Europace. 2025;27(11). doi:10.1093/europace/euaf251

BibTeX
@article{Chan2025,
  author = {Chan, Yi-Hsin and Kao, Yi-Wei and Chen, Shao-Wei and Chao, Tze-Fan},
  title = {Performance of DOAC and HAS-BLED scores in predicting major bleeding in Asian patients with non-valvular atrial fibrillation receiving direct oral anticoagulants},
  journal = {Europace},
  year = {2025},
  volume = {27},
  number = {11},
  doi = {10.1093/europace/euaf251}
}
Kostenlos starten →